About Ampersand Capital
Ampersand Capital is a private equity firm founded in 1988. It is primarily based in Wellesley, United States. As of Aug 2026, Ampersand Capital has a portfolio of 75 companies, comprising 75 funding rounds and 19 acquisitions. In the last 12 months, it has participated in 2 acquisitions. The firm primarily invests in companies based in United States and Germany. Its portfolio is spread across a wide range of sectors from Healthcare to Life Sciences. Most recently it acquired stakes in Beacon Intelligence on Jun 30, 2026.
Overall Ampersand Capital portfolio has seen 6 IPOs and 42 acquisitions, namely Stereotaxis, ANI Pharmaceuticals and Confluent Medical Technologies. A lot of funds co-invest with Ampersand Capital, with names like Pappas Capital sharing a substantial percentage of its portfolio.
Ampersand Capital has a team of 54 people, including 14 partners.
Key Metrics
Founded Year
1988
Location
Wellesley, United States
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Ampersand Capital's Portfolio
Ampersand Capital has a portfolio of 75 companies. They have invested in a total of 75 companies. Their most recent investment was in Lexington Medical (PE round) on Apr 11, 2025. Here are the most recent investments by Ampersand Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Apr 11, 2025 | PE | 3253 | - | |
Dec 09, 2024 | PE | 8464 | - | |
Jun 14, 2023 | Series A | 1740 | ||
Jun 12, 2023 | Series A | 5964 | - |
_1526993164512.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Ampersand Capital has acquired 19 companies. Their most recent acquisition was of Beacon Intelligence on Jun 30, 2026. Here are the most recent acquisitions by Ampersand Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jun 30, 2026 | Company offering clinical trial data and analysis service | - | 2015 | |
Feb 12, 2026 | CMO specializing in semi-solid and liquid dosage form manufacturing | - | 1986 | |
Jul 21, 2025 | Designs, manufactures and distributes plastic high performance packaging services | - | 1991 | |
Nov 07, 2024 | CDMO focused on drug substance development, analytical, and quality & regulatory compliance services | - | 2002 |
Here is the portfolio snapshot of Ampersand Capital:
Investments by Year
The maximum number of investments were made in 2019
Acquisitions by Year
The maximum number of acquisitions were made in 2019
Portfolio by Location
Companies are primarily in United States and Germany
Portfolio by Sector
Companies are primarily in Healthcare
Team profile of Ampersand Capital
Ampersand Capital has a team of 54 members including 14 Partners and 9 Principals located in United States, Netherlands and 4 more locations. Ampersand Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Ampersand Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Wellesley | - | - | |
Partner | Wellesley | - | - | |
Partner | Amsterdam | - | - | |
Partner | Boston | - | - | |
Partner | Wellesley | - | - | |
Partner | United States | - | - | |
Partner | Wellesley | - | - | |
Partner | Wellesley | - | - | |
Partner | Paris | - | - | |
Partner | - | - | - | |
Partner | Chattanooga | - | - |
Co-investors of Ampersand Capital
Over the past 38 years, 24 investors have co-invested in Ampersand Capital's portfolio companies.
- Top Co-investors of Ampersand Capital: 24 investors entered a company along with Ampersand Capital. These include investors like Pappas Capital (2 companies).
Ampersand Capital News
•
Ampersand Capital Partners Recognized Among GrowthCap's Top Private Equity Firms of 2026GlobeNewswire•Aug 27, 2026•Ampersand Capital
•
Ampersand Partner Melanie Fan Recognized as a Top Woman Leader in Growth InvestingGlobeNewswire•Jul 07, 2026•Ampersand Capital
•
•
Purna Pharmaceuticals Names Marc Verbruggen as Managing DirectorGlobeNewswire•Jun 04, 2026•Ampersand Capital, Purna
•
Ampersand Capital Partners Closes Oversubscribed Fund at $1.5 Billion Hard CapGlobeNewswire•May 28, 2026•Ampersand Capital
•
Ampersand Capital Partners Completes Sale of Tjoapack to AlcamiGlobeNewswire•May 05, 2026•Tjoapack, Ampersand Capital
•
Ampersand Capital Partners Named a Top Growth Equity Firm of 2025 by GrowthCapGlobeNewswire•Feb 13, 2026•Ampersand Capital
•
Ampersand Capital Partners Acquires Purna PharmaceuticalsBenzinga•Feb 12, 2026•Ampersand Capital, Purna
•
Specac Acquires Amax Precision Ltd to Expand Global OEM CapabilitiesGlobeNewswire•Jan 21, 2026•Ampersand Capital, Specac, Amaxprecision
•
